This study shows that the disease resistance and survival rate of Penaeus monodon in a larval rearing systems can be enhanced by supplementing with antagonistic or non-antagonistic probiotics. The antagonistic mode of action of Pseudomonas MCCB 102 and MCCB 103 against vibrios was demonstrated in larval mesocosm with cultures having su⁄cient concentration of antagonistic compounds in their culture supernatant. Investigations on the antagonistic properties of Bacillus MCCB 101, Pseudomonas MCCB 102 and MCCB 103 and Arthrobacter MCCB 104 against Vibrio harveyi MCCB 111under in vitro conditions revealed that Pseudomonas MCCB 102 and MCCB 103 were inhibitory to the pathogen. These inhibitory properties were further con¢rmed in the larval rearing systems of P. monodon. All these four probionts signi¢cantly improved larval survival in long-term treatments as well as when challenged with a pathogenic strain ofV. harveyi MCCB111. We could demonstrate that Pseudomonas MCCB 102 and MCCB 103 accorded disease resistance and a higher survival rate in P. monodon larval rearing systems through active antagonism of vibrios, whereas Bacillus MCCB 101 and Arthrobacter MCCB 104 functioned as probiotics through immunostimulatory and digestive enzyme-supporting modes of action.
Introduction
Globally, penaeid shrimps rank sixth in terms of quantity and second in terms of value among all the taxonomic groups of aquatic animals cultivated (FAO 2006) . The intensi¢cation of shrimp culture brought in a host of diseases, among which white spot disease caused by the white spot syndrome virus (WSSV) and luminescent vibriosis caused by Vibrio harveyi have been the scourge for nearly two decades Pang, Zhang, Zhong, Chen, Li & Austin 2006; Defoirdt, Boon, Sorgeloos, Verstraete & Bossier 2007) . Luminescent vibriosis is particularly severe during the larval stages and sporadically causes temporary closure of economic activities in shrimp larviculture clusters. The successful completion of the larval cycle requires appropriate technologies to maintain the healthy microbial balance of the system, thus preventing the outbreak of luminescent vibriosis. Traditional technology followed intensive water exchange and/or application of disinfectants and antimicrobials to complete the larval cycle successfully (Holmstrom, Graslund,Wahlstrom, Poungshompoo, Bengtsson & Kautsky 2003) . However, the emergence of antibiotic-resistant pathogens with the threat of gene transfer to human pathogens, and environmental issues pertaining to wastewater discharge led to the development of alternative biological tools to manage diseases. In this context, manipulation of microbial balance in the larval rearing tanks by introducing non-pathogenic probiotic strains isolated from native environment became a promising technology (Liao, Su & Chang 2001; Vine, Leukes & Kaiser 2006; Defoirdt et al. 2007; Guo, Liu, Cheng, Chang, Lay, Hsu, Yang & Chen 2009 ). Early de¢nitions of probiotics included only the organisms that, when delivered through feed, improved the health and survival of the hosts (Fuller 1989) . However, the de¢nition was expanded to include also the organisms that created a favourable environment for the growth and well-being of the host animals by their transience through the gastrointestinal tract or merely by their presence in the water (Gatesoupe 1999; Verschuere, Rombaut, Sorgeloos & Verstraete 2000) . Survival of ¢sh and shell¢sh larvae is increasingly reliant on the incidental microbiota of the eggs, rearing water and the live food organisms supplemented during the ¢rst feeding stages (Singh, Lakshmanaperumalswamy & Chandramohan 1989; Olafsen 2001) . Therefore, manipulating the aquatic environment with known probiotic strains can positively in£uence the well-being of shrimp larvae during larviculture (Verschuere, Rombaut, Huys, Dhont, Sorgeloos & Verstraete 1999; Verschuere et al. 2000) .
The demand for probiotics has resulted in the £ooding of the market with preparations having little or no scienti¢c documentation (Decamp, Moriarty & Lavens 2008) . Although di¡erent microorganisms have been identi¢ed as potential probiotics, their e⁄cacy at the ¢eld level has not been elucidated completely (Balca Ł zar, Blas, Ruiz-Zarzuela, Cunningham, Vendrell & Mu¤ zquiz 2006). There is a need to understand the host^microbe interactions and their in£u-ence on the resident £ora so that probiotic applications can be tailored to the situation and not empirically as is the current practice. Such an approach is hampered by the sparse information on the mechanism of action of the candidate strains and the inability of the organism to produce bioactive molecules at the required concentration under in vivo conditions. The evidence gained so far shows that the probable mechanism of action of probiotics in vitro includes secretion of inhibitory substances, digestive enzymes and stimulating the non-speci¢c immune system of the animals (Balca Ł zar Previously, we isolated from shrimp culture systems Pseudomonas and Micrococcus spp. (reclassi¢ed as Arthrobacter spp. in this study), which inhibited the growth of Vibrio spp. under in vitro conditions through inhibitory compounds (Jayaprakash, Pai, Anas, Preetha, Philip & Singh 2005; Vijayan, Singh, Jayaprakash, Alavandi, Pai, Preetha, Rajan & Santiago 2006) . The inhibitory compound of Pseudomonas spp. was identi¢ed as pyocyanin and the conditions for production were optimized (Preetha 2006; Preetha, Jayaprakash, Philip & Singh 2007) . In the present study, we investigated the replication of microbial antagonism observed in vitro under in situ conditions in Penaeus monodon larval mesocosms and the e¡ects of antagonistic and non-antagonistic probiotics on larval survival when challenged by V. harveyi MCCB 111. The identities of all strains at the genus level were ascertained at 98% homology to the type strain for which a maximum score was obtained in the BLAST algorithm (Altschul, Madden, SchÌ¡er, Zhang, Zhang, Miller & Lipman 1997) . The isolate MCCB 104 identi¢ed earlier as Micrococcus based on the phenotypic features (Jayaprakash et al. 2005) was reassigned to the genus Arthrobacter based on the 16S rRNA gene sequence obtained in this study.
Materials and methods

Bacteria
In vitro antagonism assay and co-culture experiments
Antagonism of the four putative probionts was tested using disc di¡usion assay (Jayaprakash et al. 2005) . Brie£y, each of the bacterial isolates were grown in 20 g L À 1 salinity ZB on a shaker (120 rpm) at 28 AE 1 1C for 5 days. ZoBell's marine agar plates were swabbed with 0.5 mL overnight grown culture (1OD at A 600 ) of the target bacterial isolates (87 isolates of V. harveyi). Aliquots (20 mL) of the four bacterial cultures were dispensed onto the 6 mm diameter discs prepared fromWhatman no.1 ¢lter papers separately in triplicate. Antagonism among the four putative probionts was also tested. The plates were incubated for 24 h at 28 1C and the formation of a zone of clearing around the discs was considered to be a positive indication of inhibitory activity. The zone of inhibition around the discs was recorded after 24 h using the HiAntibiotic Zone Scale (Himedia, Mumbai, Maharashtra, India). Antagonism of the cell-free supernatant of the four putative probiotic bacteria was also tested. The four cultures were grown in ZB for 5 days on a shaker (120 rpm) at 28 AE 1 1C. Cells were pelleted by centrifugation (10 000 g, 4 1C, 10 min), the pH of the supernatant was adjusted to 7.0 and then passed through a 0.2 mm pore-size cellulose-acetate membrane ¢lter (Sartorius, Goettingen, Germany). Inhibitory activity against 87 V. harveyi isolates and the four probionts was detected using the disc di¡usion method as described above.
In vitro co-culture experiments of MCCB 102 and MCCB 103 with V. harveyi MCCB 111 were carried out independently following the method of Gram, Melchiorsen, Spanggaard, Huber and Nielsen (1999) . They were pre-cultured separately in ZB at 28 AE 1 1C on a shaker at 120 rpm overnight. From the above cultures, V. harveyi MCCB 111 was inoculated in 100 mL ZB to obtain an initial cell count of approximately 10 3 CFU mL
, whereas the initial levels of MCCB 102 and MCCB 103 in those £asks were 0, 10 4 , 10 5 , 10 6 and 10 7 CFU mL À 1 respectively. The £asks were incubated at 28 AE 1 1C on a shaker (120 rpm), and samples (1mL) were withdrawn at 24-h intervals for determination of the cell count. Counts of V. harveyi were estimated using H&L medium (Hugh and Leifson1953). Tubes containing 4 mL of H&L medium were inoculated with 1mL aliquots of a serially 10-fold diluted culture and overlayed with sterile liquid para⁄n and incubated at 28 AE 1 1C for 24 h. The fermentative growth of V. harveyi MCCB 111 led to a change in the pH of the medium. The highest dilution, which showed growth and pH change, was used to calculate the count of V. harveyi MCCB 111 in the sample (1 Â 10 n , where n is the highest dilution that showed a fermentative reaction) and expressed as log 10 CFU mL
. The cell count of Pseudomonas MCCB 102 and MCCB 103 was monitored on pseudomonas isolation agar (PIA) (Himedia) using the spread plate method. In a separate experiment, overnight-grown Pseudomonas MCCB 102 and MCCB 103 were inoculated in 100 mL ZB to obtain an initial concentration of 10 4 CFU mL
. The £asks were incubated at 28 AE 1 1C on a shaker (120 rpm), and samples (6 mL) were withdrawn at 24-h intervals for determination of the cell count and the concentration of pyocyanin secreted. The cell counts of Pseudomonas MCCB 102 and MCCB 103 were measured as mentioned above. Pyocyanin was assayed by extracting 5 mL culture supernatant with 3 mL of chloroform. This was then re-extracted in 1mL 0.2 N HCl to give a pink-coloured solution. The absorbance of this solution was measured at 520 nm and the concentration in micrograms of pyocyanin produced per millilitre of culture supernatant determined by multiplying the absorbance at 520 nm by a factor 17.072 following Essar, Eberly, Hadero and Crawford (1990). Also, the 1 H NMR spectra of the pyocyanin secreted by Pseudomonas MCCB 102 and 103 were recorded on a Bruker AMX 400 (Fallender, Switzerland) high-resolution multinuclear FT-NMR spectrometer operating at 400 MHz and compared with standard pyocyanin. CdCl 3 was used as the solvent and tetramethylsilane (TMS) was used as the internal standard.
Co-cultures of MCCB 101 and MCCB 104 with V. harveyi MCCB 111 were carried out individually at the same initial cell numbers as above. Counts of the pathogen were monitored by withdrawing daily1-mL samples that were serially diluted 10-fold and 0.2 mL aliquots spread plated on TCBS agar and ZA plates. The plates were incubated at 28 AE 1 1C for 24 h and the colonies obtained on TCBS were counted and expressed as log 10 CFU mL À 1 of V. harveyi in the coculture. Both the Gram-positive bacteria (MCCB 101 and MCCB 104) did not grow on TCBS agar and could be easily di¡erentiated fromV. harveyi on ZA based on colony characteristics. MCCB 104 formed yellow nonluminescent colonies while those of MCCB 101, apart from being non-luminescent, were rough and white. All co-culture combinations were maintained in duplicate and the experiments were repeated twice.
In situ e¡ect of long-term treatment with the putative probionts on P. monodon larvae and postlarvae
Groups of 2000 P. monodon larvae at Protozoea I stage were introduced into ¢ve 100-l ¢bre-reinforced plastic (FRP) tanks and reared for 38 days until metamorphosis to postlarva (PL)-30 at a commercial shrimp hatchery. The e¡ect of the four putative probiotics MCCB101, MCCB104, MCCB102 and MCCB103 on the health and survival of P. monodon larvae was assessed independently. One group (n 5 2000) was maintained as the control without any probiotic exposure. All probiotics were pre-cultured in ZB at 28 AE 1 1C for 5 days and added to the rearing water every 2 days to obtain a ¢nal cell count of10 6 CFU mL À 1
. The larvae, protozoea I to mysis III, were maintained on a diet of Chaetoceros spp. (at 80 000^130000 cells mL
) and thereafter from PL-1 on freshly hatched Artemia nauplii (at 0.5^1individual mL À 1 ). Water in the tanks was increased to 100 L gradually until conversion to PL-1, following which 25^30% water was exchanged daily. The physico-chemical parameters of the rearing water such as, total ammonia, nitrite, pH, salinity and temperature were monitored regularly following standard methods (Clesceri, Greenberg & Eaton 1998) . Three water and larval samples were drawn from each tank once in 3 days for monitoring the total heterotrophic bacterial population (TPC) and total Vibrio count (TVC). Water samples (1mL) were serially diluted 10-fold and 0.2-mL was spread on ZA and TCBS agar plates in duplicate. Ten larvae from each group were washed gently in sterile seawater to remove loosely adhering particles and macerated in 1mL of sterile seawater, serially diluted10-fold and 0.2 mL spread on ZA and TCBS in duplicate. All plates were incubated at 28 AE 1 1C for 24^72 h and those having 30^300 colonies were taken to estimate the bacterial counts, which were expressed as log 10 CFU mL À 1 and CFU larvae À 1 for water and larval samples respectively.
The health of the postlarva (PL-30) was assessed (20 from each group) and scored by microscopic observation for features such as muscle opaqueness, deformities, size variation, gut content, colour and condition of the hepatopancreas, epibiont fouling, intestinal persistalsis and muscle to gut ratio as per the FAO guidelines (FAO 2003) . A formalin stress test was also conducted by subjecting100 postlarvae from each group to 100 ppm formalin for 1h and then monitoring them in normal rearing water for another 3 h. The ¢nal survival in each group was taken when the larvae reached PL-30.
Challenge test with V. harveyi
Three groups of 30 postlarvae (PL-24) from each of the treatments (probiotic treated and control) above were transferred to plastic containers (3 L capacity). From the control group, two sets of 30 PL each were maintained. They were acclimatized for 24 h, following which an overnight culture of the luminescent bacterium V. harveyi MCCB 111 was added to water to obtain10 6 CFU mL & Mohamed 2003). One group (probiotic untreated) of 3 Â 30 PL was maintained as negative control and not challenged. An ad libitum feeding regime with freshly hatched Artemia nauplii and probiotic addition as mentioned above was continued. The total vibrio and luminescent bacterial counts of water and larvae were assessed on ZA and TCBS agar as mentioned in the previous section on the ¢rst and the third day when the experiment was concluded.
Statistical analysis
The results of the long-term treatment experiment (when the larvae reached PL-30) were compared statistically using w 2 test. The e¡ects of the probiotics on the total vibrio population, luminescent bacteria and survival after challenge withV. harveyi were assessed using ANOVA, and the means of the di¡erent treatment groups were compared using the least signi¢cant di¡erence (LSD) multiple range test at a 5% level of signi¢cance.
Results
In vitro antagonism assay and co-culture experiments
In the antagonism assay, the culture and cell-free supernatants of the putative probionts Pseudomonas MCCB 102 and MCCB 103 inhibited all the 87 isolates of V. harveyi tested (Fig. 1) . However, the zone of inhibition obtained with the culture and cell-free supernatants of MCCB 104 was turbid (a thin layer of cell growth is observed) against all theV. harveyi isolates (Fig. 1) . The cells isolated from the turbid zone exhibited normal growth in ZB as well as on ZA plates, which indicated that the antagonistic molecule produced by Arthrobacter MCCB 104 was not inhibitory to V. harveyi MCCB111. Arthrobacter MCCB 104 did not inhibit Bacillus MCCB 101, Pseudomonas MCCB 102 and MCCB 103. Neither the culture nor the cellfree supernatant of Bacillus MCCB 101 was inhibitory to any of the isolates tested. The antagonism exhibited by Pseudomonas MCCB 102 and MCCB 103 against V. harveyi MCCB 111 was further con¢rmed in the co-culture assay. Pseudomonas MCCB 102 inhibited V. harveyi MCCB 111 in co-culture when the initial cell count of the putative probiont was 410 5 CFU mL À 1 (Fig. 2a) . However, similar inhibition of V. harveyi MCCB 111 by Pseudomonas MCCB 103 was obtained only at initial cell counts 410 6 CFU mL À 1 of the putative probiont (Fig. 2b) .
This di¡erence could be attributed to the variation in the concentration of pyocyanin secreted by MCCB 102 and MCCB 103 ( Fig. 2c and d) . Although, both MCCB 102 and 103 begin to produce pyocyanin from the late log phase and peak in the stationary phase, it was consistently higher in the culture supernatant of MCCB102. Lower cell counts of Pseudomonas MCCB 102 and MCCB 103 allowed initial growth of V. harveyi MCCB 111 ostensibly due to insu⁄cient pyocyanin in the culture media. Its concentration, however, increased upon continued incubation thus never allowing the cell densities of the pathogen to reach close to that of the control. In contrast, V. harveyi MCCB 111 growth was not inhibited in co-cultures with Bacillus MCCB 101 and Arthrobacter MCCB 104 even at 10 8 CFU mL À 1 initial densities of the probionts (Tables 1 and 2 ). Growth of the probionts was not a¡ected by V. harveyi MCCB 111 at any stage in the co-cultures (data not shown). Proton NMR spectra of pyocyanin secreted by Pseudomonas MCCB102 (top) and 103 (middle) shows a good similarity to that of the pure pyocyanin sample (Fig. 3) .
The in vitro antagonism of vibrios observed with Pseudomonas MCCB 102 and MCCB 103 was replicated during the in situ long-term treatment experiment. The total vibrio population was signi¢cantly lower (Po0.05) in the rearing water and larvae of the tanks that were supplemented with Pseudomonas MCCB 102 and MCCB 103 (Figs 4 and 5) . Notably, vibrios were not detected in the larval samples from these tanks until metamorphosis to PL-8. In agreement with the in vitro results, there was no e¡ect on the TVC in the earing water and larvae of the groups supplemented with Bacillus MCCB 101and Arthrobacter MCCB 104 compared with that of the untreated control (Figs 4 and 5) . In all treatment groups, luminescent bacteria could not be detected at any stage during the experiment. The mortality of P. monodon larvae was signi¢cantly lower (w 2 5228.9, Po0.05) in all probiotic treatment groups compared with that in the untreated control (Fig.6) . The highest TVC (Figs 4 and 5) and maximum cumulative mortality (Fig. 6) were observed in the tanks without any probiotic application, indicating the pathogenicity of vibrios. Interestingly, larval survival was signi¢cantly and comparatively higher (Po0.05) in the group that received Arthrobacter MCCB 104 compared with the other probionts tested. When 20 larvae from each group were examined under the microscope, they were all transparent, with their guts full, dark hepatopancreas, high intestinal peristalsis, no fouling or deformities on the exoskeleton or gills, muscle: gut ratio at the sixth abdominal segment 43:1 and a uniform size (%CVo15%) ( Table 3) . Larvae in all treatment groups did not show any signs of weakness when subjected to formalin stress test, indicating the good health of the larvae (Supporting information Table S2). In conclusion, all the four bacterial putative probionts tested could signi¢cantly improve P. monodon larval survivals, and the application of the pseudomonads MCCB102 and103 resulted in reducing the Vibrio population during the early larval stages.
Challenge with V. harveyi MCCB 111
We demonstrated the ability of the four putative probionts to protect P. monodon postlarva fromVibrio infection by challenging with the opportunistic pathogenV. harveyi MCCB 111 (Fig.7) . On completion of larval rearing with and without the putative probiotics, postlarva (PL30) were challenged with 10 6 CFU mL À 1 V. harveyi MCCB 111 and the cumulative mortality was monitored after 3 days. Signi¢-cantly higher mortality was observed in the larvae reared without any probiotics, con¢rming the pathogenicity ofV. harveyi MCCB 111 (Fig.7a) . The mortality was signi¢cantly lower (Po0.05) in the groups that were previously treated with the probiotics. Luminescent bacterial counts (LBC) were signi¢cantly lower (Po0.05) in the groups that received pre-emptive treatment with Pseudomonas MCCB 102 and MCCB 103, indicating that the antagonistic compound present in the rearing water negatively impacted the V. harveyi population (Fig. 7b) . No luminescent bacteria were detected in any of the larval samples that received the probionts while they were recovered from the control that was not under probiotic treatment (Fig. 7c) . This showed that the V. harveyi MCCB 111 had indeed infected the larvae and was the cause of larval mortality.Vibrio harveyi was estimated in all samples from the luminous bacterial counts obtained from ZA enumeration plates. Interestingly, their counts obtained on TCBS were always one log lower than those on ZA and therefore only the ZA counts were considered. In conclusion, the larvae pre-emptively treated with the four putative probionts were e¡ectively healthier and could successfully ward o¡ V. harveyi infection. It was further con¢rmed that the application of Pseudomonas MCCB 102 and MCCB 103 to the rearing water could e¡ectively reduce the V. harveyi population.
Discussion
We could demonstrate that the disease resistance and survival rate of P. monodon in larval rearing systems can be promoted by the supplementation of probiotics. The in vitro antagonism of the four probionts assessed using the disc di¡usion and co-culture experiments showed that Pseudomonas MCCB 102 and MCCB 103 e¡ectively inhibited the growth of V. harveyi MCCB 111. The viability of V. harveyi in the turbid zone of clearance obtained with Arthrobacter MCCB 104 indicated that it was neither bactericidal nor bacteriostatic. The inhibition of V. harveyi MCCB 111 by Pseudomonas MCCB 102 and MCCB 103 could be attributed to the production of the antagonistic compound pyocyanin and siderophores, secreted into the culture broth (Preetha 2006; Vijayan et al. 2006; Preetha et al. 2007) . Pyocyanin and other phenazine compounds secreted by £uorescent pseudomonads mediated inhibition of other bacteria due to their unusual redox properties, which resulted in an enhanced production of hydroxide (OH À ) and super Cox, Edeker & Britigan 1990; Britigan, Roeder, Rasmussen, Shasby, McCormick & Cox 1992) . Co-cultures allow the study of the interaction between two organisms in terms of antagonism and competition for micronutrients particularly under nutrient-limiting conditions (Gram et al. 1999) . The production of pyocyanin by the Pseudomonas isolates used in the co-cultures apparently gave them a competitive advantage overV. harveyi MCCB 111mediated by the killing of the pathogen. However, Bacillus MCCB 101 and Arthrobacter MCCB 104 could not gain competitive advantage overV. harveyi MCCB111because the former did not produce any antagonistic molecules and the antagonistic property exhibited by the latter in vitro was so weak too have control over the pathogen.
A major challenge in the in situ demonstration of the antagonistic mode of action of probiotics in aquaculture systems is to ensure su⁄cient concentration of an antagonistic compound in the culture supernatant. Previously, we optimized the fermentation conditions of Pseudomonas MCCB 102 and MCCB 103 to maximize the secretion of pyocyanin in the culture supernatant (Preetha et al. 2007) and in the present study, in situ antagonism was successfully achieved through regular application of the culture. It is evident that Pseudomonas MCCB 102 and MCCB 103 could not only control the vibrio population but could also signi¢cantly improve larval survival in shrimp larval mesocosms. On the other hand, signi¢cant differences in TVC were not observed in rearing water and larvae of tanks supplemented with Bacillus MCCB 101 and Arthrobacter MCCB 104. The production of phenazine compounds by £uorescent pseudomonads is profoundly in£uenced by environmental factors, a plausible reason for the lack of sustained activity when applied in the environment (van Rij,Wesselink, Chin-A-Woeng, Bloemberg & Lugtenberg 2004) , which can be overcome by regular replenishment of the probiont. Therefore, the application of probiotics with antagonistic mode of action is a viable PL30  PL8  PL2  M2  Z3  Z1  PL30  PL8  PL2  M2  Z3  Z1   PL30  PL8  PL2  M2  Z3  Z1  PL30 method to control vibriosis in hatcheries, provided the minimum inhibitory concentration of an antagonistic compound in the culture supernatant is maintained.
Interestingly, although we did not expect a signi¢-cant change in cumulative mortality in larvae reared with Bacillus MCCB 101 and Arthrobacter MCCB 104, it was the lowest in these groups in the in situ experiment. Based on the in vitro experiments, it could be established that this e¡ect was not due to antagonism or competitive inhibition of pathogens. Strains belonging to Bacillus spp. were among the ¢rst bacterial species to be identi¢ed as probiotics for shrimp culture and have been reported to mediate their protection from pathogens through antagonism and/or immunostimulation of the host animals (Moriarty 1998; Rengpipat, Tunyanun, Fast, Piyatiratitivorakul & Menasveta 2003; Hong, Duc & Cutting 2005; Guo et al. 2009 ). Additionally, Bacillus spp. could increase the growth and survival of Fenneropenaeus indicus by supplementing the digestive system of the host with microbial enzymes and thereby increasing the nutrient utilization (Ziaei-Nejad, Rezaei, Takami, Lovett, 
Mirvaghe¢ & Shakouri 2006). On the other hand,
Arthrobacter XE-7 did not signi¢cantly improve the survival of P. chinensis postlarva in mono-treatments but did so only in the presence of V. parahaemolyticus, V. anguillarum and V. neries (Li, Tan, Mai, Ai, Zhang, Xu, Liufu & Ma 2006) . In the present study, Arthrobacter MCCB 104 signi¢cantly improved larval survivals in mono-treatments as well as in the presence of V. harveyi. Consequently, the increased survival rate observed with the application of Bacillus MCCB 101 and Arthrobacter MCCB 104 could be due to an immunostimulatory e¡ect and/or a digestive systemsupporting e¡ect because both the strains did not negatively a¡ect the growth of V. harveyi MCCB 111. An extension of the current work on the e¡ect of Bacillus MCCB 101 and Arthrobacter MCCB 104 on the expression of immune genes and the digestive enzyme pro¢le of the target animal would provide comprehensive information to prove the immunostimulatory and digestive enzyme-supporting properties of Bacillus MCCB 101 and Arthrobacter MCCB 104. The protection conferred by the probionts was con¢rmed by challenging the larvae (PL30) with the luminescent bacteriumV. harveyi MCCB 111. Notably, mortality was signi¢cantly lower (Po0.05) in all the probiotic treatments. A high percentage of mortality in the control animals (without probiotic treatment) con¢rms the pathogenicity of V. harveyi MCCB 111. Although the TVC was not signi¢cantly di¡erent in the rearing water between various treatment groups, it was once again markedly lower in the larvae treated with Pseudomonas. Importantly, luminescent bacteria were signi¢cantly lower in the rearing water and larvae of the Pseudomonas MCCB 102 and 103 treatment groups, con¢rming their antagonistic property. The absence of luminescent bacteria in the larvae of the groups that received Bacillus MCCB 101 and Arthrobacter MCCB 104 further points towards an immunostimulatory mode of action by these bacteria. Figure 7 Percentage mortality of Penaeus monodon postlarvae, reared with and without the putative probionts following a challenge withVibrio harveyi MCCB 111 (a); total vibrio population (unshaded bars) and luminescent bacterial population (shaded bars) in rearing water (b) and larvae (c); total vibrio population and total luminescent bacterial population; Ã values signi¢cant at Po0.05. CV, coe⁄cient of variation.
Aquaculture Research, 2010, 41, 847^860 Probiotic treatment of Penaeus monodon larvae S S Pai et al.
In conclusion, the present study, along with our earlier reports (Jayaprakash et al. 2005; Vijayan et al. 2006; Preetha et al. 2007) , demonstrates that the Pseudomonas MCCB 102 and MCCB 103 suppress the vibrio population in a P. monodon larval rearing system through an antagonistic mode of action. The primary requirement for the demonstration of antagonistic mode of action of probiotics in aquaculture systems is the assurance of the minimum inhibitory concentration of the antagonistic compound in the culture, which is supplemented to the larval rearing tank. Also, this study points towards other possible modes of action such as immunostimulation and enhanced food acceptance leading to improved general health of target animal by probiotics, as evident in the case of Bacillus MCCB 101and Arthrobacter MCCB 104. However, further studies at the molecular level are required to elucidate the role of MCCB101and MCCB104 in modulating the expression of immune genes and improving the general health of P. monodon. 
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